Aegerion Pharma (AEGR) – Analyst Ratings
-
Leerink Partners Cuts Price Target on Aegerion Pharma (AEGR) Following 1Q Miss and Guidance
-
Leerink Partners Reiterates Outperform on Aegerion Pharma (AEGR) - PT to $15
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AEGR Stock Lookup